US 11,266,353

Application 15/750,923 · Granted Mar 8, 2022

Support system and method

Estimated expiration

July 11, 2037

10y 235d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTGB2016052468: Resource not found (404)
Earliest effective filing
Aug 8, 2016
+ 20 years
Aug 8, 2036
PTA +337d
Jul 11, 2037
No TD
—
Final
Jul 11, 2037

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
February 7, 2018
Earliest effective filing
August 8, 2016
Issue date
March 8, 2022
PTA
+337 days
Base expiry (before PTA)
August 8, 2036

August 8, 2016 + 20 years = August 8, 2036 + 337 PTA days = July 11, 2037

  • National stage entry of application PCTGB2016052468, filed Aug 8, 2016

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 15/750,923 · US 11,266,353

PatentReply compiles the prosecution history behind US 11,266,353: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11266353

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.